Clinical Trial Update: Glycemic Load, Weight Loss and Cardiovascular Disease Risk [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update from the University of Sydney evaluating glycemic load, weight loss, and cardiovascular disease risk in overweight or obese adults…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Snippet

Sponsor: University of Sydney | Conditions: Overweight, Obesity | Phase 1 | Status: COMPLETED